Businesses that are compliant with applicable regulations should be worth more than those that are not. Meade & Roach, LLP assists clients in assessing their corporate integrity needs. This includes a range of services from regulatory due diligence to contract database organization and management.
Compliance issues are complex; the typical financial due diligence rarely provides the mechanism to find out whether or not a potential acquisition or merger partner is in compliance, particularly with respect to Medicare / Medicaid regulations. A non-compliant company can pose devastating financial consequences for the successor company if non-compliance is not identified before closing the deal.
While the performance of a thorough due diligence may protect a buyer from financial responsibility for past false claims or tort liabilities, the information obtained from the due diligence can make or break the deal, affect the purchase price, or result in delays while the regulatory matters are resolved. Therefore, the amount and type of due diligence performed by our attorneys has depended on the competitive sensitivity of the issues and the desired pace of the negotiations.
Meade & Roach, LLP assists acquiring companies in developing due diligence work plans at the beginning of each engagement that address issues unique to the contemplated transaction. We work side-by-side with our client's financial due diligence experts in order to quantify the level of financial risk that may be involved. We also assist our clients with development of risk management solutions for identified issues in the event the transaction is consummated.
We can assist in current or advanced corporate integrity with the following services:
Contract database organization.
Assessment of contract risks and contract legal implications that can affect the value
of the company (such as contract renewal issues; rate bargaining)
Assessment of financial covenants (in loans, letters of credit, etc) that could affect sale and renegotiation for more favorable terms in advance of sale
Technology risks
Corporate governance assessment (bylaws, etc)
Implications of corporate management of assessments
